Phototherapy devices are used for treating neonatal jaundice and various skin conditions. These devices are extensively used in procedures such as reducing of bilirubin serum concentration or curing bilirubin toxicity.
For a sample copy of the report, please click:- https://www.factmr.com/connectus/sample?flag=S&rep_id=76
Phototherapy devices are also used in treating hyperbilirubinemia in both haemolytic and non-hemolytic conditions. These devises can effectively reduce the need for frequent blood transfusion. Phototherapy devices are facilitating greater patient convenience and hence witnessing widespread adoption in hospitals and clinics.
Increasing prevalence of skin ailments such as psoriasis and eczema across the globe and advancement of phototherapy technology is expected to influence the global phototherapy devices market over the next couple of years. As the number of patients with skin conditions continue to soar, urgency of developing advance treatment modules also grows in parallel. The introduction of cost-effective phototherapy devices based on LED technology that are more efficient than the conventional devices is bringing hope to patients. Over the years, phototherapy treatment has continuously evolved due to the arrival of new technological peripherals. Factors as such, have been instrumental in driving the adoption of phototherapy devices. Phototherapy devices are being increasingly used in treating neonatal jaundice, which is common among new born babies with high amount of bilirubinlevels. However, the introduction of alternative mode of treatments and potential risks of side-effects coupled with stringent regulations on product approval remain a major challenge for manufacturers of phototherapy devices. As per the latest report published by Fact.MR, the global phototherapy devices market will expand at 4.7% CAGR over the forecast period (2017-2022).
View Full Report@:- https://www.factmr.com/report/76/phototherapy-devices-market
North America to Lead the Global Phototherapy Devices Market
In terms of revenue, the phototherapy devices market in North America is expected to remain highly attractive throughout the forecast period. In addition, the region’s market is projected to expand at little under 4% CAGR over 2022. Meanwhile, the markets in Asia-Pacific excluding Japan (APEJ) and Europe are also projected to register a steady growth over the next five years.
Competition Tracking
Key players mentioned in Fact.MR’s report include Drägerwerk AG & Co. KGaA, Medela AG, General Electric Company, Natus Medical Incorporated, Hill-Rom, Solarc Systems Inc., The Daavlin Company, Schulze & Böhm GmbH, Medisana AG, Guangzhou Beautylife Electronic Technology co.,Ltd, Herbert Waldmann GmbH & Co. KG, Philips Lighting Holding B.V., National Biological Corp., Nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems Pvt. Ltd., ALFAMEDIC S.R.O., NINGBO DAVID MEDICAL DEVICE CO., LTD., Heal Force Bio-Meditech Holdings Limited, Natus Medical Incorporated and DIXION.
Request for the Customization of the report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=76
About Us
We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.
Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.
Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.
For More Information Kindly Contact:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Mail: sales@factmr.com
Read Blog: https://theheraldmedia.com/
For a sample copy of the report, please click:- https://www.factmr.com/connectus/sample?flag=S&rep_id=76
Phototherapy devices are also used in treating hyperbilirubinemia in both haemolytic and non-hemolytic conditions. These devises can effectively reduce the need for frequent blood transfusion. Phototherapy devices are facilitating greater patient convenience and hence witnessing widespread adoption in hospitals and clinics.
Increasing prevalence of skin ailments such as psoriasis and eczema across the globe and advancement of phototherapy technology is expected to influence the global phototherapy devices market over the next couple of years. As the number of patients with skin conditions continue to soar, urgency of developing advance treatment modules also grows in parallel. The introduction of cost-effective phototherapy devices based on LED technology that are more efficient than the conventional devices is bringing hope to patients. Over the years, phototherapy treatment has continuously evolved due to the arrival of new technological peripherals. Factors as such, have been instrumental in driving the adoption of phototherapy devices. Phototherapy devices are being increasingly used in treating neonatal jaundice, which is common among new born babies with high amount of bilirubinlevels. However, the introduction of alternative mode of treatments and potential risks of side-effects coupled with stringent regulations on product approval remain a major challenge for manufacturers of phototherapy devices. As per the latest report published by Fact.MR, the global phototherapy devices market will expand at 4.7% CAGR over the forecast period (2017-2022).
View Full Report@:- https://www.factmr.com/report/76/phototherapy-devices-market
North America to Lead the Global Phototherapy Devices Market
In terms of revenue, the phototherapy devices market in North America is expected to remain highly attractive throughout the forecast period. In addition, the region’s market is projected to expand at little under 4% CAGR over 2022. Meanwhile, the markets in Asia-Pacific excluding Japan (APEJ) and Europe are also projected to register a steady growth over the next five years.
Competition Tracking
Key players mentioned in Fact.MR’s report include Drägerwerk AG & Co. KGaA, Medela AG, General Electric Company, Natus Medical Incorporated, Hill-Rom, Solarc Systems Inc., The Daavlin Company, Schulze & Böhm GmbH, Medisana AG, Guangzhou Beautylife Electronic Technology co.,Ltd, Herbert Waldmann GmbH & Co. KG, Philips Lighting Holding B.V., National Biological Corp., Nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems Pvt. Ltd., ALFAMEDIC S.R.O., NINGBO DAVID MEDICAL DEVICE CO., LTD., Heal Force Bio-Meditech Holdings Limited, Natus Medical Incorporated and DIXION.
Request for the Customization of the report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=76
About Us
We are an insights-driven global market intelligence company with a unique purpose: enabling organizations make better decisions. We do this by creating an ecosystem where an eclectic cognitive collaboration between human imagination and data science leads to path breaking ideas.
Our vision is to foster a pervasive culture where critical business decisions are taken on the basis of facts rather than assumptions and perceptions.
Our mission is empowerment – empowerment of free-thought; empowerment of fact-based decisions; empowerment of decisive action.
For More Information Kindly Contact:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Mail: sales@factmr.com
Read Blog: https://theheraldmedia.com/
No comments:
Post a Comment